Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
VERITAS-Pro: a new measure of adherence to prophylactic regimens in haemophilia
Haemophilia, 11/25/09
Duncan N et al. – The VERITAS–Pro has greater utility than a global or informal rating of adherence because it represents a quantified and validated measure of adherence from the patient's perspective and it divides adherence into specific areas, allowing insight into particular issues underlying non–adherence. This tool may increase sensitivity to adherence problems and allow more targeted interventions to enhance adherence.
Today in Coagulation/Bleeding Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Decreased plasmin resistance by clots of a homophenotypic A[alpha] R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release)
Blood Coagulation & Fibrinolysis, 02/09/10
Identification and functional characterization of a novel nonsense mutation in FGA accounting for congenital afibrinogenemia in six Egyptian patients
Blood Coagulation & Fibrinolysis, 02/09/10
A case of nocardiasis complicated with meningitis in a patient with immune thrombocytopenic purpura
Blood Coagulation & Fibrinolysis, 02/09/10
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): A phase II randomised trial
The Lancet Oncology - Online First, 02/09/10
Plasma and cerebrospinal fluid pharmacokinetics of topotecan in a phase I trial of topotecan, tamoxifen, and carboplatin, in the treatment of recurrent or refractory brain or spinal cord tumors
Cancer Chemotherapy and Pharmacology, 02/09/10
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer
Cancer Chemotherapy and Pharmacology, 02/09/10
Article Search
Sponsor
Sponsor


See Latest Articles


